Daratumumab for the treatment of multiple myeloma.

Touzeau C, Moreau P.

DOI: 10.1080/14712598.2017.1322578
Published: 2017-05-02
Container: Expert Opin Biol Ther
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/14712598.2017.1322578,
  title = {Daratumumab for the treatment of multiple myeloma.},
  author = {Touzeau C and  Moreau P.},
  year = {2017},
  journal = {Expert Opin Biol Ther},
  doi = {10.1080/14712598.2017.1322578},
  url = {https://doi.org/10.1080/14712598.2017.1322578}
}

RIS

TY  - JOUR
TI  - Daratumumab for the treatment of multiple myeloma.
AU  - Touzeau C
AU  -  Moreau P.
PY  - 2017
JO  - Expert Opin Biol Ther
DO  - 10.1080/14712598.2017.1322578
UR  - https://doi.org/10.1080/14712598.2017.1322578
ER  -

APA

C, T., & P., M. (2017). Daratumumab for the treatment of multiple myeloma.. Expert Opin Biol Ther. https://doi.org/10.1080/14712598.2017.1322578

Source records

europe-pmc · retrieved 2026-09-27T02:34:31.137Z